Irene Ghobrial Selected Research

Irene Ghobrial Research Topics

Disease

15	Multiple Myeloma 12/2020 - 08/2005
13	Neoplasms (Cancer) 01/2022 - 05/2004
6	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2015 - 09/2006
3	Thrombocytopenia (Thrombopenia) 04/2015 - 08/2005
2	Disease Progression 01/2022 - 04/2015
2	Paraproteinemias (Monoclonal Gammopathy) 09/2013 - 08/2007
2	Venous Thromboembolism 02/2013 - 06/2010
2	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 08/2008 - 08/2005
2	Renal Insufficiency (Renal Failure) 01/2007 - 11/2006
2	Bone Diseases (Bone Disease) 01/2007 - 11/2006
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Nephrotic Syndrome (Syndrome, Nephrotic) 12/2018
1	Necrosis 11/2018
1	Hemorrhage 04/2015
1	Epistaxis (Nosebleed) 04/2015
1	Atrial Fibrillation 04/2015
1	Cardiac Arrhythmias (Arrythmia) 04/2015
1	Neutropenia 04/2015
1	Lymphoma (Lymphomas) 09/2013
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2013
1	Chronic Disease (Chronic Diseases) 04/2012
1	Amyloidosis 04/2012
1	Hematologic Neoplasms (Hematological Malignancy) 04/2012
1	Anemia 09/2009
1	Chromosome Aberrations (Chromosome Abnormalities) 11/2006
1	Monoclonal Gammopathy of Undetermined Significance 09/2006
1	Bone Resorption 04/2006
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2004

Drug/Important Bio-Agent (IBA)

5	Bortezomib (Velcade)FDA Link 09/2009 - 11/2006
4	Proteins (Proteins, Gene)FDA Link 12/2018 - 08/2007
4	Immunoglobulin M (IgM)IBA 09/2013 - 09/2006
4	Pharmaceutical PreparationsIBA 02/2013 - 08/2005
3	Lenalidomide (CC 5013)FDA Link 01/2022 - 06/2010
2	Biological ProductsIBA 04/2009 - 08/2007
2	TOR Serine-Threonine KinasesIBA 08/2008 - 08/2005
2	temsirolimus FDA Link 08/2008 - 08/2005
2	Phosphotransferases (Kinase)IBA 08/2008 - 08/2005
2	Thalidomide (Thalomid)FDA Link 08/2007 - 04/2006
1	Melphalan (Alkeran)FDA LinkGeneric 01/2022
1	Green Fluorescent ProteinsIBA 01/2019
1	VaccinesIBA 01/2019
1	Chimeric Antigen ReceptorsIBA 01/2019
1	nephrinIBA 12/2018
1	NPHS2 proteinIBA 12/2018
1	nitroxylIBA 11/2018
1	MetalsIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	PolymersIBA 11/2018
1	Agammaglobulinaemia Tyrosine KinaseIBA 04/2015
1	ibrutinibIBA 04/2015
1	Fish OilsIBA 04/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2013
1	Immunoglobulins (Immunoglobulin)IBA 01/2013
1	Amyloid (Amyloid Fibrils)IBA 04/2012
1	Proteasome InhibitorsIBA 04/2009
1	Protein Kinase C betaIBA 08/2007
1	Rituximab (Mabthera)FDA Link 08/2007
1	Monoclonal AntibodiesIBA 08/2007
1	CholesterolIBA 08/2007
1	Immunologic Factors (Immunomodulators)IBA 08/2007
1	LigandsIBA 08/2007
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 08/2007
1	Stem Cell FactorIBA 08/2007
1	B-Cell Activating FactorIBA 08/2007
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 08/2007
1	Immunoglobulin A (IgA)IBA 01/2007
1	pomalidomideIBA 04/2006
1	Interleukin-3 (Interleukin 3)IBA 08/2005
1	Messenger RNA (mRNA)IBA 08/2005
1	Cyclin D1IBA 08/2005
1	ibritumomab tiuxetan (Zevalin)FDA Link 05/2004
1	Immunoconjugates (Immunoconjugate)IBA 05/2004

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2007
2	Drug Tapering 08/2008 - 08/2005
1	Immunotherapy 01/2019
1	Autologous Transplantation 12/2010
1	Stem Cell Transplantation 08/2007
1	Radioimmunotherapy 05/2004